All data are based on the daily closing price as of July 11, 2025
n

NewGenIvf Group

NIVF
0.87 USD
-0.06
-6.45%
* previous day closing price

Overview

Last close
0.87 usd
Market cap
3.74M usd
52 week high
246.80 usd
52 week low
0.28 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.7366
Price/Book Value
7.1504
Enterprise Value
6.57M usd
EV/Revenue
1.2101
EV/EBITDA
272.6647

Key financials

Revenue TTM
5.43M usd
Gross Profit TTM
1.83M usd
EBITDA TTM
-1.14M usd
Earnings per Share
-293.1 usd
Dividend
N/A usd
Total assets
3.78M usd
Net debt
2.57M usd

About

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
  • Symbol
    NIVF
  • Exchange
    NASDAQ
  • Isin
    VGG0544E1051
  • Country
    Thailand
  • Sector
    Healthcare
  • Industry
    Medical Care Facilities
  • CEO
  • Headquarter
    Bangkok
  • Web site
    https://newgenivf.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top